Adenomatous polyposis coli heterozygous knockout mice display hypoactivity and age-dependent working memory deficits

Frontiers in Behavioral Neuroscience

Volumn , Issue DECEMBER, 2011, Pages

  Koshimizu, Hisatsugu ^a,b   Fukui, Yasuyuki ^c   Takao, Keizo ^b,d   Ohira, Koji ^a,b   Tanda, Koichi ^c,e   Nakanishi, Kazuo ^c   Toyama, Keiko ^a,b   Oshima, Masanobu ^f   Taketo, Makoto Mark ^g   Miyakawa, Tsuyoshi ^a,b,d  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^f KANAZAWA UNIVERSITY   (Japan)

^g KYOTO UNIVERSITY   (Japan)

Author keywords

Apc; Behavioral test battery; Hypoactivity; Locomotor activity; Working memory performance

Indexed keywords

ADENOMATOUS POLYPOSIS COLI GENE; ADULT ANIMAL; AGE; ANEMIA; ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; FEAR; FORCED SWIMMING TEST; HETEROZYGOSITY; HOT PLATE TEST; HYPOACTIVITY; KNOCKOUT MOUSE; LIGHT DARK CYCLE; LOCOMOTION; MAZE TEST; MEMORY DISORDER; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NEUROPSYCHOLOGICAL TEST; NONHUMAN; OPEN FIELD TEST; PREPULSE INHIBITION; ROTAROD TEST; SOCIAL INTERACTION; STARTLE REFLEX; TUMOR SUPPRESSOR GENE; WORKING MEMORY;

EID: 84855243503     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2011.00085     Document Type: Article

References (42)

1. Araya, R., Noguchi, T., Yuhki, M., Kitamura, N., Higuchi, M., Saido, T. C., Seki, K., Itohara, S., Kawano, M., Tanemura, K., et al. (2006). Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice. Neurobiol. Dis 24, 334-344.
2. Arguello, P. A., and Gogos, J. A. (2006). Modeling madness in mice: one piece at a time. Neuron 52, 179-196.
3. Bhat, R. V., Baraban, J. M., Johnson, R. C., Eipper, B. A., and Mains, R. E. (1994). High levels of expression of the tumor suppressor gene APC during development of the rat central nervous system. J. Neurosci 14, 3059-3071.
4. Brzózka, M. M., Radyushkin, K., Wichert, S. P., Ehrenreich, H., and Rossner, M. J. (2010). Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain. Biol. Psychiatry 68, 33-40.
5. Cui, D. H., Jiang, K. D., Jiang, S. D., Xu, Y. F., and Yao, H. (2005). The tumor suppressor adenomatous polyposis coli gene is associated with susceptibility to schizophrenia. Mol. Psychiatry 10, 669-677.
6. Denny, S. D., Kuchibhatla, M. N., and Cohen, H. J. (2006). Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am. J. Med 119, 327-334.
7. Farías, G. G., Godoy, J. A., Cerpa, W., Varela-Nallar, L., and Inestrosa, N. C. (2010). Wnt signaling modulates pre- and postsynaptic maturation: therapeutic considerations. Dev. Dyn 239, 94-101.
8. Fowler, M. G., Whitt, J. K., Lallinger, R. R., Nash, K. B., Atkinson, S. S., Wells, R. J., and McMillan, C. (1988). Neuropsychologic and academic functioning of children with sickle cell anemia. J Dev Behav Pediatr 9, 213-220.
9. Freese, J. L., Pino, D., and Pleasure, S. J. (2010). Wnt signaling in development and disease. Neurobiol. Dis 38, 148-153.
10. Gainetdinov, R. R., Mohn, A. R., and Caron, M. G. (2001). Genetic animal models: focus on schizophrenia. Trends Neurosci 24, 527-533.
11. Gerber, D. J., Hall, D., Miyakawa, T., Demars, S., Gogos, J. A., Karayiorgou, M., and Tonegawa, S. (2003). Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc. Natl. Acad. Sci. U.S.A100, 8993-8998.
12. Golub, M. S., Hogrefe, C. E., Germann, S. L., Capitanio, J. P., and Lozoff, B. (2006). Behavioral consequences of developmental iron deficiency in infant rhesus monkeys. Neurotoxicol Teratol 28, 3-17.
13. Ivaniutsin, U., Chen, Y., Mason, J. O., Price, D. J., and Pratt, T. (2009). Adenomatous polyposis coli is required for early events in the normal growth and differentiation of the developing cerebral cortex. Neural Dev 4, 3-3.
14. Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., and Clevers, H. (1997). Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275, 1784-1787.
15. LeDoux, J. E., Cicchetti, P., Xagoraris, A., and Romanski, L. M. (1990). The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning. J. Neurosci 10, 1062-1069.
16. Lijam, N., Paylor, R., McDonald, M. P., Crawley, J. N., Deng, C.-X., Herrup, K., Stevens, K. E., Maccaferri, G., McBain, C. J., Sussman, D. J., et al.(1997). Social Interaction and Sensorimotor Gating Abnormalities in Mice Lacking Dvl1. Cell 90, 895-905.
17. MacDonald, B. T., Tamai, K., and He, X. (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17, 9-26.
18. Mehl, K. A., Davis, J. M., Berger, F. G., and Carson, J. A.(2005). Myofiber degeneration/regeneration is induced in the cachectic ApcMin/+ mouse. Journal of Applied Physiology 99, 2379-2387.
19. Miyakawa, T., Leiter, L. M., Gerber, D. J., Gainetdinov, R. R., Sotnikova, T. D., Zeng, H., Caron, M. G., and Tonegawa, S. (2003). Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc. Natl. Acad. Sci. U.S.A 100, 8987-8992.
20. Moser, A. R., Pitot, H. C., and Dove, W. F. (1990). A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324.
21. Nakajima, R., Takao, K., Huang, S. M., Takano, J., Iwata, N., Miyakawa, T., and Saido, T. C. (2008). Comprehensive behavioral phenotyping of calpastatin-knockout mice. Mol Brain. 1, 7.
22. van Noort, M., Meeldijk, J., van der Zee, R., Destree, O., and Clevers, H. (2002). Wnt signaling controls the phosphorylation status of beta-catenin. J. Biol. Chem 277, 17901-17905.
23. Oshima, M., Oshima, H., Kitagawa, K., Kobayashi, M., Itakura, C., and Taketo, M. (1995a). Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. U.S.A 92, 4482-4486.
24. Powell, C. M., and Miyakawa, T. (2006). Schizophrenia-Relevant Behavioral Testing in Rodent Models: A Uniquely Human Disorder? Biological Psychiatry 59, 1198-1207.
25. Raj, D. S. C. (2009). Role of Interleukin-6 in the Anemia of Chronic Disease. Seminars in Arthritis and Rheumatism 38, 382-388.
26. Saneyoshi, T., Kume, S., Amasaki, Y., and Mikoshiba, K. (2002). The Wnt/calcium pathway activates NF-AT and promotes ventral cell fate in Xenopus embryos. Nature 417, 295-299.
27. Senda, T., Iino, S., Matsushita, K., Matsumine, A., Kobayashi, S., and Akiyama, T. (1998). Localization of the adenomatous polyposis coli tumour suppressor protein in the mouse central nervous system. Neuroscience 83, 857-866.
28. Senda, T., Iizuka-Kogo, A., Onouchi, T., and Shimomura, A. (2007). Adenomatous polyposis coli (APC) plays multiple roles in the intestinal and colorectal epithelia. Med Mol Morphol 40, 68-81.
29. Senda, T., Shimomura, A., and Iizuka-Kogo, A. (2005). Adenomatous polyposis coli (Apc) tumor suppressor gene as a multifunctional gene. Anat Sci Int 80, 121-131.
30. Shibata, M., Yamasaki, N., Miyakawa, T., Kalaria, R. N., Fujita, Y., Ohtani, R., Ihara, M., Takahashi, R., and Tomimoto, H. (2007). Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke 38, 2826-2832.
31. Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietilainen, O. P. H., Mors, O., Mortensen, P. B., et al. (2009a). Common variants conferring risk of schizophrenia. Nature 460, 744-747.
32. Takao, K., and Miyakawa, T. (2006a). Investigating gene-to-behavior pathways in psychiatric disorders: the use of a comprehensive behavioral test battery on genetically engineered mice. Ann. N. Y. Acad. Sci 1086, 144-159.
33. Takao, K., and Miyakawa, T. (2006b). Light/dark transition test for mice. J Vis Exp. 1, 104.
34. Takao, K., Yamasaki, N., and Miyakawa, T. (2007). Impact of brain-behavior phenotyping of genetically-engineered mice on research of neuropsychiatric disorders. Neurosci Res 58, 124-32.
35. Taketo, M. M. (2006). Mouse models of gastrointestinal tumors. Cancer Sci 97, 355-361.
36. Tamada, K., Tomonaga, S., Hatanaka, F., Nakai, N., Takao, K., Miyakawa, T., Nakatani, J., and Takumi, T. (2010). Decreased exploratory activity in a mouse model of 15q duplication syndrome; implications for disturbance of serotonin signaling. PLoS One 5, e15126.
37. Tanda, K., Nishi, A., Matsuo, N., Nakanishi, K., Yamasaki, N., Sugimoto, T., Toyama, K., Takao, K., and Miyakawa, T. (2009). Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice. Mol Brain 2, 19.
38. Wedgwood, S., Lam, W. K., Pinchin, K. M., Markham, A. F., Cartwright, E. J., and Coletta, P. L. (2000). Characterization of a brain-selective transcript of the Adenomatous polyposis coli tumor suppressor gene. Mamm. Genome 11, 1150-1153.
39. Weinberg, J., Levine, S., and Dallman, P. R. (1979). Long-term consequences of early iron deficiency in the rat. Pharmacol. Biochem. Behav 11, 631-638.
40. Yamasaki, N., Maekawa, M., Kobayashi, K., Kajii, Y., Maeda, J., Soma, M., Takao, K., Tanda, K., Ohira, K., Toyama, K., et al. (2008). Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders. Mol Brain 1, 6.
41. Zeng, H., Chattarji, S., Barbarosie, M., Rondi-Reig, L., Philpot, B. D., Miyakawa, T., Bear, M. F., and Tonegawa, S.(2001). Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 107, 617-29.
42. Zhao, L., Kim, K. W., Ikeda, Y., Anderson, K. K., Beck, L., Chase, S., Tobet, S. A., and Parker, K. L.(2008) Central nervous system-specific knockout of steroidogenic factor1 results in increased anxiety-like behavior. Mol Endocrinol. 22, 1403-1415.